Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company focused on developing RNA medicines to treat rare diseases. As an investor interested in ARCT, it is important to understand the technical analysis of the stock to make informed decisions. Technical analysis involves studying historical price and volume data to predict future price movements. Several technical indicators can be used to analyze ARCT stock.

One commonly used indicator is the Relative Strength Index (RSI), which measures the speed and change of price movements. A high RSI value indicates overbought conditions, while a low RSI value suggests oversold conditions. The RSI for ARCT stock can provide insight into whether the stock is overbought or oversold.

Arcturus Therapeutics Holdings  (ARCT) Technical Analysis

Arcturus Therapeutics Holdings Inc (ARCT) offers a comprehensive technical analysis of key indicators including RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. Analyze market trends with reliable data and make informed investment decisions. Understand the stock's performance without using verbs in this informative and detailed analysis.

Arcturus Therapeutics Holdings Inc (ARCT) Technical Analysis: RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Arcturus Therapeutics Holdings Inc., a late-stage clinical messenger RNA medicines and vaccine company, focuses on the development of infectious disease vaccines and other products within liver and respiratory rare diseases. Its technology platforms include LUNAR lipid-mediated delivery and STARR mRNA. The company is developing ARCT-810 (LUNAR-OTC), a mRNA-based therapeutic candidate, which is in Phase 2 clinical trial for treating ornithine transcarbamylase deficiency; and ARCT-154 (LUNAR-COV19), a mRNA vaccine candidate that is in Phase 3 arm of a Phase 1/2/3 study in Vietnam for the treatment of COVID-19, as well as ARCT-032 (LUNAR-CF), a mRNA therapeutic candidate for cystic fibrosis. The company was founded in 2013 and is headquartered in San Diego, California.

Arcturus Therapeutics Holdings 

NASDAQ

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	56.45	Neutral	7.6%
auto_graphMACD	1.13	Neutral	-28.0%
auto_graphCCI	79.62	Neutral	65.9%
auto_graphADX	24.30	Neutral	-21.5%
auto_graphATR	3.29	Buy	-
auto_graphWILLR	-23.01	Neutral	183.7%
auto_graphROC	36.90	Neutral	-5.0%
auto_graphSTOCHRSI	0.00	Buy	-99.8%

Buy	2	-75.00%
Hold	6	-25.00%
Sell	0	-100.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Arcturus Therapeutics Holdings (ARCT) Technical Analysis

Keep an eye on Arcturus Therapeutics Holdings

Frequently Asked Questions

What are the technical signals for Arcturus Therapeutics Holdings (ARCT) stock based on the last 30 days?

Take Your Investments to a Whole New Level